Business

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled

articleBullfrog Ai Holdings, Inc.September 25, 20234/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-founder-and-ceo-vin-singh-to-present-company-overview-at-biofuture-2023
BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

About this update from Bullfrog Ai Holdings, Inc.

[{"type":"text","content":"GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (\"BullFrog AI\" or the \"Company\"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its founder and CEO Vin Singh will give a presentation at BioFuture 2023 (Oct. 4-6, 2023) on the Company’s recent partnerships, revenue and growth strategy, and portfolio of prodrugs in early-stage clinical development. The presentation will take place on October 5, 2023 at Lotte New York Palace in New York City. Presenter: Vin Singh, Founder and CEO, BullFrog AI Date/Time: October 5, 2023 2:30-3:30 p.m. EDT Location: Adams - Fourth Floor - Lotte New York Palace, 455 Madison Avenue, New York, NY About BullFrog AIBullFrog AI is a technology-enabled drug development company that creates and analyzes networks of biological clinical and real-world data spanning from early discovery to late-stage clinical trials. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development using its proprietary bfLEAP™ artificial intelligence platform. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics. For more information visit BullFrog AI at:Website: https://bullfrogai.com LinkedIn: https://www.linkedin.com/company/bullfrogai/ Safe Harbor StatementThis press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as \"may,\" \"should,\" \"expects,\" \"anticipates,\" \"contemplates,\" \"estimates,\" \"believes,\" \"plans,\" \"proje...

More updates from Bullfrog Ai Holdings, Inc.